These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 238221

  • 1. Intensification of central catecholaminergin and serotonergic processes by the hypothalamic factors MIF and TRF and by angiotensin II.
    Huidobro-Toro JP, Scotti de Carolis A, Longo VG.
    Pharmacol Biochem Behav; 1975; 3(2):235-42. PubMed ID: 238221
    [Abstract] [Full Text] [Related]

  • 2. Action of two hypothalamic factors (TRH, MIF) and of angiotensin II on the behavioral effects of L-DOPA and 5-hydroxytryptophan in mice.
    Huidobro-Toro JP, De Carolis AS, Longo VG.
    Pharmacol Biochem Behav; 1974; 2(1):105-9. PubMed ID: 4364044
    [No Abstract] [Full Text] [Related]

  • 3. Synthetic melanocyte stimulating hormone release-inhibiting factor (MIF). Part III: effect of L-prolyl-N-methyl-D-leucyl-glycinamide and MIF on biogenic amine turnover.
    Pugsley TA, Lippmann W.
    Arzneimittelforschung; 1977; 27(12):2293-6. PubMed ID: 23796
    [Abstract] [Full Text] [Related]

  • 4. Synthetic MIF analogues. Part II: Dopa potentiation and fluphenazine antagonism.
    Voith K.
    Arzneimittelforschung; 1977; 27(12):2290-3. PubMed ID: 23795
    [Abstract] [Full Text] [Related]

  • 5. Prolyl-leucyl-glycine amide (PLG) and thyrotropin-releasing hormone (TRH): DOPA potentiation and biogenic amine studies.
    Plotnikoff NP.
    Prog Brain Res; 1975; 42():11-23. PubMed ID: 730
    [No Abstract] [Full Text] [Related]

  • 6. Central effects of thyrotropin-releasing factor (TRF); interaction with some antipsychotic drugs.
    Mora S, Loizzo A, Longo VG.
    Pharmacol Biochem Behav; 1976 Mar; 4(3):279-82. PubMed ID: 819939
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Correlation of nitric oxide (NO) activity and gonadal function in Japanese quail, Coturnix coturnix japonica following temporal phase relation of serotonergic and dopaminergic oscillations.
    Kumar P, Chaturvedi CM.
    Anim Reprod Sci; 2008 Jun; 106(1-2):48-64. PubMed ID: 17512145
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effects of the tripeptides TRH, MIF and MAF on the cerebral dopaminergic system.
    Klusha B, Georgiev V, Petkov V, Markovska V.
    Acta Physiol Pharmacol Bulg; 1983 Jun; 9(2):14-9. PubMed ID: 6140814
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Different effects of harmine on plasma concentrations of L-dopa and on cerebral dopamine metabolism in rabbits and rats.
    Meneguz A, Betto P, Ricciarello G.
    Pharmacology; 1994 Jun; 48(6):360-6. PubMed ID: 8047555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.